Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Cardoso, Inês Peça, A. Roque (2012)
Antibody-conjugated nanoparticles for therapeutic applications.Current medicinal chemistry, 19 19
Tennyson Doane, C. Burda (2012)
The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy.Chemical Society reviews, 41 7
G. Das, A. Nicastri, M. Coluccio, F. Gentile, P. Candeloro, G. Cojoc, C. Liberale, F. Angelis, E. Fabrizio (2010)
FT‐IR, Raman, RRS measurements and DFT calculation for doxorubicinMicroscopy Research and Technique, 73
A. Tabaković, M. Kester, James Adair (2012)
Calcium phosphate-based composite nanoparticles in bioimaging and therapeutic delivery applications.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 4 1
M. O'brien, N. Wigler, M. Inbar, R. Rosso, E. Grischke, A. Santoro, R. Catane, D. Kieback, P. Tomczak, S. Ackland, F. Orlandi, L. Mellars, L. Alland, C. Tendler (2004)
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.Annals of oncology : official journal of the European Society for Medical Oncology, 15 3
Jared Bee, D. Chiu, Suzanne Sawicki, Jennifer Stevenson, K. Chatterjee, E. Freund, J. Carpenter, T. Randolph (2009)
Monoclonal antibody interactions with micro- and nanoparticles: adsorption, aggregation, and accelerated stress studies.Journal of pharmaceutical sciences, 98 9
B. Palazzo, M. Iafisco, M. Laforgia, N. Margiotta, G. Natile, C. Bianchi, D. Walsh, S. Mann, N. Roveri (2007)
Biomimetic Hydroxyapatite–Drug Nanocrystals as Potential Bone Substitutes with Antitumor Drug Delivery PropertiesAdvanced Functional Materials, 17
C. Bardelli, Marilena Sala, U. Cavallazzi, M. Prat (2005)
Agonist Met antibodies define the signalling threshold required for a full mitogenic and invasive program of Kaposi's Sarcoma cells.Biochemical and biophysical research communications, 334 4
R. Lu, Yu-Ling Chang, Min-shan Chen, Han‐Chung Wu (2011)
Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery.Biomaterials, 32 12
N. Roveri, B. Palazzo, M. Iafisco (2008)
The role of biomimetism in developing nanostructured inorganic matrices for drug deliveryExpert Opinion on Drug Delivery, 5
Yu-Jen Lu, Kuo-Chen Wei, C. Ma, Shin-Yi Yang, Jyh-Ping Chen (2012)
Dual targeted delivery of doxorubicin to cancer cells using folate-conjugated magnetic multi-walled carbon nanotubes.Colloids and surfaces. B, Biointerfaces, 89
A. Al-Kattan, S. Girod-Fullana, C. Charvillat, Hélène Ternet-Fontebasso, P. Dufour, J. Dexpert‐Ghys, V. Santran, Julie Bordère, B. Pipy, J. Bernad, C. Drouet (2012)
Biomimetic nanocrystalline apatites: Emerging perspectives in cancer diagnosis and treatment.International journal of pharmaceutics, 423 1
Lara Lacerda, A. Bianco, M. Prato, Kostas Kostarelos (2006)
Carbon nanotubes as nanomedicines: from toxicology to pharmacology.Advanced drug delivery reviews, 58 14
G. Cortesina, T. Martone, E. Galeazzi, M. Olivero, A. Stefani, M. Bussi, G. Valente, P. Comoglio, M. Renzo (2000)
Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastasesInternational Journal of Cancer, 89
Thomas Morgan, H. Muddana, E. Altinoglu, Sarah Rouse, A. Tabaković, T. Tabouillot, T. Russin, S. Shanmugavelandy, P. Butler, P. Eklund, Jong Yun, M. Kester, James Adair (2008)
Encapsulation of organic molecules in calcium phosphate nanocomposite particles for intracellular imaging and drug delivery.Nano letters, 8 12
M. Prat, R. Narsimhan, T. Crepaldi, M. Nicotra, P. Natali, P. Comoglio (1991)
The receptor encoded by the human C‐MET oncogene is expressed in hepatocytes, epithelial cells and solid tumorsInternational Journal of Cancer, 49
P. Michieli, M. Mazzone, C. Basilico, Silvia Cavassa, A. Sottile, L. Naldini, P. Comoglio (2004)
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor.Cancer cell, 6 1
T. Libermann, Harris Nusbaum, N. Razon, R. Kris, I. Lax, H. Soreq, N. Whittle, M. Waterfield, A. Ullrich, J. Schlessinger (1985)
Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial originNature, 313
James Adair, Mylisa Parette, E. Altinoglu, M. Kester (2010)
Nanoparticulate alternatives for drug delivery.ACS nano, 4 9
J. Turner, Jana Dawson, D. Sullivan (2012)
Nuclear export of proteins and drug resistance in cancer.Biochemical pharmacology, 83 8
Menghan Shi, Karyn Ho, A. Keating, M. Shoichet (2009)
Doxorubicin‐Conjugated Immuno‐Nanoparticles for Intracellular Anticancer Drug DeliveryAdvanced Functional Materials, 19
G. Sahay, Daria Alakhova, A. Kabanov (2010)
Endocytosis of nanomedicines.Journal of controlled release : official journal of the Controlled Release Society, 145 3
V. Uskoković, D. Uskoković (2011)
Nanosized hydroxyapatite and other calcium phosphates: chemistry of formation and application as drug and gene delivery agents.Journal of biomedical materials research. Part B, Applied biomaterials, 96 1
E. Vigna, G. Pacchiana, M. Mazzone, C. Chiriaco, L. Fontani, C. Basilico, Selma Pennacchietti, P. Comoglio (2008)
"Active" cancer immunotherapy by anti-Met antibody gene transfer.Cancer research, 68 22
I. Sidorov, P. Prabakaran, D. Dimitrov (2007)
Non-Covalent Conjugation of Nanoparticles to Antibodies via Electrostatic Interactions—A Computational ModelJournal of Computational and Theoretical Nanoscience, 4
S. Misra, A. Dybowska, D. Berhanu, S. Luoma, E. Valsami-Jones (2012)
The complexity of nanoparticle dissolution and its importance in nanotoxicological studies.The Science of the total environment, 438
Prashansa Agrawal, S. Barthwal, R. Barthwal (2009)
Studies on self-aggregation of anthracycline drugs by restrained molecular dynamics approach using nuclear magnetic resonance spectroscopy supported by absorption, fluorescence, diffusion ordered spectroscopy and mass spectrometry.European journal of medicinal chemistry, 44 4
A. Cantelmo, R. Cammarota, D. Noonan, Chiara Focaccetti, P. Comoglio, Maria Prat, Adriana Albini (2010)
Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growthOncogene, 29
N. Nukolova, H. Oberoi, S. Cohen, A. Kabanov, T. Bronich (2011)
Folate-decorated nanogels for targeted therapy of ovarian cancer.Biomaterials, 32 23
M. Clague (2011)
Met Receptor: A Moving TargetScience Signaling, 4
J. Delgado-López, M. Iafisco, I. Rodríguez, A. Tampieri, M. Prat, J. Gómez-Morales (2012)
Crystallization of bioinspired citrate-functionalized nanoapatite with tailored carbonate content.Acta biomaterialia, 8 9
S. Neumann, A. Kovtun, I. Dietzel, M. Epple, R. Heumann (2009)
The use of size-defined DNA-functionalized calcium phosphate nanoparticles to minimise intracellular calcium disturbance during transfection.Biomaterials, 30 35
Annalisa Petrelli, Giorgio Gilestro, S. Lanzardo, P. Comoglio, N. Migone, S. Giordano (2002)
The endophilin–CIN85–Cbl complex mediates ligand-dependent downregulation of c-MetNature, 416
A. Gabizon, H. Shmeeda, Y. Barenholz (2003)
Pharmacokinetics of Pegylated Liposomal DoxorubicinClinical Pharmacokinetics, 42
M. Prat, T. Crepaldi, Selma Pennacchietti, F. Bussolino, P. Comoglio (1998)
Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF.Journal of cell science, 111 ( Pt 2)
M. Iafisco, B. Palazzo, G. Martra, N. Margiotta, Sara Piccinonna, G. Natile, V. Gandin, C. Marzano, N. Roveri (2012)
Nanocrystalline carbonate-apatites: role of Ca/P ratio on the upload and release of anticancer platinum bisphosphonates.Nanoscale, 4 1
Michael Motskin, D. Wright, Karin Müller, N. Kyle, T. Gard, A. Porter, J. Skepper (2009)
Hydroxyapatite nano and microparticles: correlation of particle properties with cytotoxicity and biostability.Biomaterials, 30 19
M. Iafisco, B. Palazzo, M. Marchetti, N. Margiotta, R. Ostuni, G. Natile, M. Morpurgo, V. Gandin, C. Marzano, N. Roveri (2009)
Smart delivery of antitumoral platinum complexes from biomimetic hydroxyapatite nanocrystalsJournal of Materials Chemistry, 19
A. Faraji, P. Wipf (2009)
Nanoparticles in cellular drug delivery.Bioorganic & medicinal chemistry, 17 8
M. Gonzalez-Gaitan (2008)
The garden of forking paths: recycling, signaling, and degradation.Developmental cell, 15 2
D. Capello, Gianluca Gaidano, M. Gallicchio, A. Gloghini, Enzo Medico, Daniela Vivenza, D. Buonaiuto, L. Fassone, Gian Avanzi, Giuseppe Saglio, Maria Prat, Anna Carbone (2000)
The tyrosine kinase receptor Met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphomaLeukemia, 14
Helen Jopling, G. Howell, N. Gamper, S. Ponnambalam (2011)
The VEGFR2 receptor tyrosine kinase undergoes constitutive endosome-to-plasma membrane recycling.Biochemical and biophysical research communications, 410 2
D. Slamon, G. Clark, S. Wong, W. Levin, A. Ullrich, W. McGuire (1987)
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.Science, 235 4785
S. Pietronave, M. Iafisco, Deborah Locarno, L. Rimondini, Maria Prat (2009)
Functionalized nanomaterials for diagnosis and therapy of cancer.Journal of applied biomaterials & biomechanics : JABB, 7 2
M. Vallet‐Regí, E. Ruiz‐Hernández (2011)
Bioceramics: From Bone Regeneration to Cancer NanomedicineAdvanced Materials, 23
J. Sierra, M. Tsao (2011)
c-MET as a potential therapeutic target and biomarker in cancerTherapeutic Advances in Medical Oncology, 3
E. Altinoglu, T. Russin, James Kaiser, Brian Barth, P. Eklund, M. Kester, James Adair (2008)
Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer.ACS nano, 2 10
T. Boix, J. Gómez-Morales, J. Torrent-Burgués, A. Monfort, P. Puigdoménech, R. Rodríguez-Clemente (2005)
Adsorption of recombinant human bone morphogenetic protein rhBMP-2m onto hydroxyapatite.Journal of inorganic biochemistry, 99 5
L. Rajendran, H. Knölker, K. Simons (2010)
Subcellular targeting strategies for drug design and deliveryNature Reviews Drug Discovery, 9
S. Padhye, Sunny Guin, H. Yao, Yong-qing Zhou, Ruiwen Zhang, Ming-Hai Wang (2011)
Sustained expression of the RON receptor tyrosine kinase by pancreatic cancer stem cells as a potential targeting moiety for antibody-directed chemotherapeutics.Molecular pharmaceutics, 8 6
S. Liou, San-Yuan Chen, Hsin-yi Lee, J. Bow (2004)
Structural characterization of nano-sized calcium deficient apatite powders.Biomaterials, 25 2
S. Bose, S. Tarafder (2012)
Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review.Acta biomaterialia, 8 4
M. Iafisco, E. Varoni, M. Foggia, S. Pietronave, M. Fini, N. Roveri, L. Rimondini, M. Prat (2012)
Conjugation of hydroxyapatite nanocrystals with human immunoglobulin G for nanomedical applications.Colloids and surfaces. B, Biointerfaces, 90
Brian Barth, R. Sharma, E. Altinoglu, Thomas Morgan, S. Shanmugavelandy, James Kaiser, Christopher McGovern, G. Matters, Jill Smith, M. Kester, James Adair (2010)
Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo.ACS nano, 4 3
K. Kiyomiya, S. Matsuo, M. Kurebe (2001)
Mechanism of specific nuclear transport of adriamycin: the mode of nuclear translocation of adriamycin-proteasome complex.Cancer research, 61 6
E. Gherardi, W. Birchmeier, C. Birchmeier, G. Woude (2012)
Targeting MET in cancer: rationale and progressNature Reviews Cancer, 12
C. Boccaccio, P. Comoglio (2006)
Invasive growth: a MET-driven genetic programme for cancer and stem cellsNature Reviews Cancer, 6
G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, L. Gianni (2004)
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and CardiotoxicityPharmacological Reviews, 56
Diana Kozlova, S. Chernousova, T. Knuschke, J. Buer, A. Westendorf, M. Epple (2012)
Cell targeting by antibody-functionalized calcium phosphatenanoparticlesJournal of Materials Chemistry, 22
Jie Zhu, Lei Liao, Xiaojun Bian, J. Kong, Pengyuan Yang, Baohong Liu (2012)
pH-controlled delivery of doxorubicin to cancer cells, based on small mesoporous carbon nanospheres.Small, 8 17
J. Scheel, Sabine Weimans, A. Thiemann, E. Heisler, Martina Hermann (2009)
Exposure of the murine RAW 264.7 macrophage cell line to hydroxyapatite dispersions of various composition and morphology: assessment of cytotoxicity, activation and stress response.Toxicology in vitro : an international journal published in association with BIBRA, 23 3
P. Comoglio, S. Giordano, L. Trusolino (2008)
Drug development of MET inhibitors: targeting oncogene addiction and expedienceNature Reviews Drug Discovery, 7
M. Volkova, R. Russell (2011)
Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and TreatmentCurrent Cardiology Reviews, 7
Nanosized drug carriers functionalized with moieties specifically targeting tumor cells are promising tools in cancer therapy, due to their ability to circulate in the bloodstream for longer periods and their selectivity for tumor cells, enabling the sparing of healthy tissues. Because of its biocompatibility, high bioresorbability, and responsiveness to pH changes, synthetic biomimetic nanocrystalline apatites are used as nanocarriers to produce multifunctional nanoparticles, by coupling them with the chemotherapeutic drug doxorubicin (DOXO) and the DO‐24 monoclonal antibody (mAb) directed against the Met/Hepatocyte Growth Factor receptor (Met/HGFR), which is over‐expressed on different types of carcinomas and thus represents a useful tumor target. The chemical‐physical features of the nanoparticles are fully investigated and their interaction with cells expressing (GTL‐16 gastric carcinoma line) or not expressing (NIH‐3T3 fibroblasts) the Met/HGFR is analyzed. Functionalized nanoparticles specifically bind to and are internalized in cells expressing the receptor (GTL‐16) but not in the ones that do not express it (NIH‐3T3). Moreover they discharge DOXO in the targeted GTL‐16 cells that reach the nucleus and display cytotoxicity as assessed in an MTT assay. Two different types of ternary nanoparticles are prepared, differing for the sequence of the functionalization steps (adsorption of DOXO first and then mAb or vice versa), and it is found that the ones in which mAb is adsorbed first are more efficient under all the examined aspects (binding, internalization, cytotoxicity), possibly because of a better mAb orientation on the nanoparticle surface. These multifunctional nanoparticles could thus be useful instruments for targeted local or systemic drug delivery, allowing a reduction in the therapeutic dose of the drug and thus adverse side effects. Moreover, this work opens new perspectives in the use of nanocrystalline apatites as a new platform for theranostic applications in nanomedicine.
Small – Wiley
Published: Nov 25, 2013
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.